These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25759584)

  • 1. Mixed nanomicelles as potential carriers for systemic delivery of Z-GP-Dox, an FAPα-based doxorubicin prodrug: formulation and pharmacokinetic evaluation.
    Zhang Y; Zhang X; Liu H; Cai S; Wu B
    Int J Nanomedicine; 2015; 10():1625-36. PubMed ID: 25759584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug.
    Huang S; Fang R; Xu J; Qiu S; Zhang H; Du J; Cai S
    J Drug Target; 2011 Aug; 19(7):487-96. PubMed ID: 21284542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells.
    Suo A; Qian J; Zhang Y; Liu R; Xu W; Wang H
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():564-73. PubMed ID: 26952460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery system.
    Xie YT; Du YZ; Yuan H; Hu FQ
    Int J Nanomedicine; 2012; 7():3235-44. PubMed ID: 22802685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomicelles based on X-shaped four-armed peglyated distearylglycerol as long circulating system for doxorubicin delivery.
    Zhang W; Sun J; Fang W; Ai X; Cai C; Tang Y; Su X; Feng Z; Liu Y; Tao M; Yan X; Chen G; He Z
    Eur J Pharm Sci; 2015 Jan; 66():96-106. PubMed ID: 25446512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery.
    Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin-H Channeled Self-Therapeutic P-gp Inhibitor Curcumin-Derived Nanomicelles for Targeting the Tumor Milieu by pH- and Enzyme-Triggered Hierarchical Disassembly.
    Das M; Joshi A; Devkar R; Seshadri S; Thakore S
    Bioconjug Chem; 2022 Feb; 33(2):369-385. PubMed ID: 35015523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Camptothecin prodrug nanomicelle based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Gao Y; Xiao Y; Liu S; Yu J
    J Biomater Sci Polym Ed; 2018 Feb; 29(2):160-180. PubMed ID: 29145770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilayer micro-dispersing system as oral carriers for co-delivery of doxorubicin hydrochloride and P-gp inhibitor.
    Feng C; Li J; Mu Y; Kong M; Li Y; Raja MA; Cheng XJ; Liu Y; Chen XG
    Int J Biol Macromol; 2017 Jan; 94(Pt A):170-180. PubMed ID: 27720963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trackable Mitochondria-Targeting Nanomicellar Loaded with Doxorubicin for Overcoming Drug Resistance.
    Zhang Y; Zhang C; Chen J; Liu L; Hu M; Li J; Bi H
    ACS Appl Mater Interfaces; 2017 Aug; 9(30):25152-25163. PubMed ID: 28697306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis.
    Ramasamy T; Poudel BK; Ruttala H; Choi JY; Hieu TD; Umadevi K; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2016 Oct; 146():152-60. PubMed ID: 27318960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
    Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
    Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro.
    Zhao YZ; Sun CZ; Lu CT; Dai DD; Lv HF; Wu Y; Wan CW; Chen LJ; Lin M; Li XK
    Cancer Lett; 2011 Dec; 311(2):187-94. PubMed ID: 21872982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of doxorubicin-loaded chitosan polymeric micelle and study on its tissue biodistribution in mice].
    Xu XY; Zhou JP; Li L; Zhang Y; Huo MR; Wang X; Lü L
    Yao Xue Xue Bao; 2008 Jul; 43(7):743-8. PubMed ID: 18819480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein-α-based doxorubicin prodrug: in-vitro and in-vivo evaluation.
    Huang S; Zhang Y; Zhong J; Pan Y; Cai S; Xu J
    Anticancer Drugs; 2018 Mar; 29(3):253-261. PubMed ID: 29346131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.